Results for tag: "Bcl 2 Like Protein"

The Bcl 2 Like Protein market is a subset of the larger oncology drugs market. Bcl 2 Like Proteins are a family of proteins that regulate apoptosis, or programmed cell death, in cells. They are important in the treatment of cancer, as they can be used to induce apoptosis in cancer cells, while leaving healthy cells unharmed. Bcl 2 Like Proteins are also used in combination with other drugs to enhance the efficacy of cancer treatments. The Bcl 2 Like Protein market is highly competitive, with many companies developing and marketing these drugs. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more